England Launches Major SMA Newborn Screening Study Following Jesy Nelson Campaign

Approximately 750,000 newborns in England will undergo screening for spinal muscular atrophy (SMA) as part of a significant new study led by the University of Oxford. This initiative aims to evaluate the feasibility and cost-effectiveness of adding SMA testing to routine post-birth heel-prick blood tests. The study is heavily influenced by the campaigning efforts of singer Jesy Nelson, whose twins were recently diagnosed with the genetic condition. Nelson has actively lobbied the UK government and gathered over 100,000 petition signatures to raise awareness and push for nationwide screening. Funded by the National Institute for Health and Care Research (NIHR), the project will commence in August across seven NHS laboratories, covering about two-thirds of births in England. The goal is to provide robust evidence to the UK National Screening Committee to support the permanent inclusion of SMA in newborn checks. Early diagnosis is critical, as existing therapies can significantly alter the disease's trajectory if administered before irreversible muscle damage occurs. Final results are expected by 2031, potentially leading to equitable access to life-changing treatments for all affected infants across the UK.